Endometrial cancer survival rates

The survival rate of endometrial cancer is related to factors such as tumor stage and degree of differentiation. The 5-year survival rate of early-stage patients can reach a high level, while the prognosis of late-stage patients is relatively poor. Endometrial cancer is an epithelial malignant tumor that occurs in the endometrium, and its prognosis mainly depends on the clinical stage when the disease is discovered.

For stage I patients who are limited to the uterus, after standard treatment, the 5-year survival rate is usually ideal. In such patients, the tumor does not invade the myometrium or only superficially infiltrates. Surgical resection combined with postoperative adjuvant treatment can effectively control the disease. In stage II patients, the tumor has involved the cervical stroma but has not extended beyond the uterus. The survival rate is lower than that in stage I but remains at a certain level. Stage III patients have regional lymph node metastasis or local spread, and their prognosis is significantly reduced. Stage IV patients have the lowest survival rate when distant metastasis occurs, and comprehensive treatments are needed to prolong survival.

In addition to clinical stage, pathological type and degree of differentiation also affect survival rate. Endometrioid adenocarcinoma has a better prognosis than special types such as serous carcinoma or clear cell carcinoma. Well-differentiated tumors are less malignant, while moderately and poorly differentiated tumors are more aggressive. Other influencing factors include patient age, underlying diseases, treatment options, etc. Young patients usually tolerate treatment better, and comorbid diseases such as diabetes and hypertension may affect the treatment effect.

It is recommended to receive standardized treatment in a timely manner after diagnosis and regular follow-up monitoring after surgery. Maintaining a healthy weight can help reduce the risk of recurrence, and moderate exercise can improve the body's immune function. During treatment, it is necessary to ensure high-quality protein intake and appropriate supplementation of vitamin D and dietary fiber. If symptoms such as abnormal vaginal bleeding or pelvic pain occur, you should seek medical attention immediately for review.